INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,990 | +150.9% | 16,774 | +67.4% | 0.00% | – |
| Q4 2022 | $123,960 | -11.3% | 10,021 | 0.0% | 0.00% | – |
| Q3 2022 | $139,793 | +1.3% | 10,021 | 0.0% | 0.00% | – |
| Q2 2022 | $138,000 | -23.3% | 10,021 | -9.4% | 0.00% | – |
| Q1 2022 | $180,000 | -46.1% | 11,064 | -46.1% | 0.00% | -100.0% |
| Q4 2021 | $334,000 | +18.0% | 20,530 | +7.7% | 0.00% | 0.0% |
| Q3 2021 | $283,000 | -24.7% | 19,066 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $376,000 | -9.2% | 18,806 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $414,000 | +13.7% | 17,922 | +21.6% | 0.00% | 0.0% |
| Q4 2020 | $364,000 | -22.1% | 14,744 | +30.8% | 0.00% | 0.0% |
| Q3 2020 | $467,000 | -86.2% | 11,275 | -84.0% | 0.00% | -87.5% |
| Q2 2020 | $3,381,000 | -37.9% | 70,594 | -18.4% | 0.01% | -46.7% |
| Q1 2020 | $5,444,000 | -53.7% | 86,463 | -8.9% | 0.02% | -37.5% |
| Q4 2019 | $11,762,000 | +28.6% | 94,919 | -31.2% | 0.02% | +20.0% |
| Q3 2019 | $9,149,000 | -12.0% | 137,876 | +5.6% | 0.02% | -9.1% |
| Q2 2019 | $10,392,000 | -26.3% | 130,607 | +3.7% | 0.02% | -31.2% |
| Q1 2019 | $14,094,000 | +34.8% | 126,000 | +21.5% | 0.03% | +23.1% |
| Q4 2018 | $10,452,000 | -19.1% | 103,696 | +1.5% | 0.03% | -3.7% |
| Q3 2018 | $12,913,000 | +1718.7% | 102,193 | +1107.8% | 0.03% | +1250.0% |
| Q2 2018 | $710,000 | +77.9% | 8,461 | +30.5% | 0.00% | +100.0% |
| Q1 2018 | $399,000 | -57.9% | 6,483 | -60.0% | 0.00% | -50.0% |
| Q4 2017 | $947,000 | +97.7% | 16,213 | +96.5% | 0.00% | +100.0% |
| Q3 2017 | $479,000 | -43.4% | 8,250 | +18.0% | 0.00% | -50.0% |
| Q2 2017 | $847,000 | +12.0% | 6,994 | +4.7% | 0.00% | 0.0% |
| Q1 2017 | $756,000 | -3.2% | 6,681 | -7.1% | 0.00% | 0.0% |
| Q4 2016 | $781,000 | -36.1% | 7,190 | -3.3% | 0.00% | 0.0% |
| Q3 2016 | $1,223,000 | +18.5% | 7,436 | +2.8% | 0.00% | -33.3% |
| Q2 2016 | $1,032,000 | +13.2% | 7,231 | +1.8% | 0.00% | +50.0% |
| Q1 2016 | $912,000 | -14.7% | 7,101 | -0.8% | 0.00% | -33.3% |
| Q4 2015 | $1,069,000 | -12.3% | 7,159 | -2.6% | 0.00% | 0.0% |
| Q3 2015 | $1,219,000 | -31.9% | 7,349 | -0.9% | 0.00% | -25.0% |
| Q2 2015 | $1,791,000 | +1.5% | 7,418 | +18.5% | 0.00% | 0.0% |
| Q1 2015 | $1,765,000 | +84.6% | 6,259 | +2.1% | 0.00% | +100.0% |
| Q4 2014 | $956,000 | -35.8% | 6,128 | -2.7% | 0.00% | -33.3% |
| Q3 2014 | $1,490,000 | -0.7% | 6,295 | -0.8% | 0.00% | 0.0% |
| Q2 2014 | $1,501,000 | +13.4% | 6,345 | +58.0% | 0.00% | 0.0% |
| Q1 2014 | $1,324,000 | +383.2% | 4,015 | 0.0% | 0.00% | +200.0% |
| Q4 2013 | $274,000 | – | 4,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |